Adocia Stock London S.E.
Stocks
0QAI
FR0011184241
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.890 EUR | -8.86% |
|
+21.58% | -25.80% |
| 06-08 | Adocia presents Phase 3 study data |  |
| 06-08 | Adocia Presents Full Phase 3 Results For BioChaperone Lispro In Type 2 Diabetes Presented at ADA 86th Scientific Sessions | CI |
| Market Cap | 84.25M 96.91M 77.5M 72.9M 137M 9.2B 138M 921M 357M 4.5B 364M 356M 15.56B | P/E 2025 |
-7.44x | P/E 2026 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 41.73M 48M 38.39M 36.11M 67.66M 4.56B 68.41M 456M 177M 2.23B 180M 176M 7.71B | EV / Sales 2025 |
31.9x | EV / Sales 2026 * | 0.92x |
| Free-Float |
90.83% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -8.86% | ||
| 1 week | +21.58% | ||
| Current month | -2.98% | ||
| 1 month | -4.31% | ||
| 3 months | -15.40% | ||
| 6 months | -25.00% | ||
| Current year | -25.80% |
| 1 week | 4.03 |  | 4.89 |
| 1 month | 3.91 | | 5.14 |
| Current year | 3.91 | | 7.45 |
| 1 year | 3.48 | | 12.24 |
| 3 years | 3.15 | | 16.16 |
| 5 years | 2.8 | | 16.16 |
| 10 years | 2.8 | | 61.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Olivier Soula
CEO | Chief Executive Officer | 55 | 11/05/2023 |
| Director of Finance/CFO | - | 23/09/2024 | |
Martin Gaudier
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Olivier Soula
BRD | Director/Board Member | 55 | 19/04/2013 |
Gérard Soula
CHM | Chairman | 80 | 24/02/2012 |
| Director/Board Member | 58 | 18/06/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.86% | +21.58% | - | - | 101M | |
| +3.23% | +2.93% | +61.50% | +113.87% | 54.54B | |
| +0.04% | +5.05% | +43.44% | +36.75% | 43.86B | |
| +3.04% | +6.61% | -13.27% | -18.06% | 22.63B | |
| +3.07% | -0.60% | -3.09% | +392.25% | 20.7B | |
| -0.53% | -0.27% | +12.68% | -37.07% | 15.84B | |
| +5.27% | +1.71% | +11.09% | -38.81% | 14.83B | |
| +0.65% | -1.04% | +25.60% | +174.70% | 13.1B | |
| -5.17% | +4.13% | +13.12% | - | 12.66B | |
| -0.27% | +4.82% | +75.35% | +104.79% | 11.56B | |
| Average | +0.05% | +0.18% | +25.16% | +91.05% | 23.3B | |
| Weighted average by Cap. | +1.52% | +0.18% | +31.63% | +90.69% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 38.39M 44.16M 35.32M 33.22M 62.25M 4.19B 62.94M 420M 163M 2.05B 166M 162M 7.09B | 38.39M 44.15M 35.31M 33.22M 62.24M 4.19B 62.93M 420M 163M 2.05B 166M 162M 7.09B |
| Net income | -13.01M -14.97M -11.97M -11.26M -21.1M -1.42B -21.33M -142M -55.22M -695M -56.18M -54.97M -2.4B | 3.98M 4.57M 3.66M 3.44M 6.45M 434M 6.52M 43.48M 16.87M 212M 17.17M 16.8M 735M |
| Net Debt | -42.52M -48.91M -39.12M -36.79M -68.95M -4.65B -69.71M -465M -180M -2.27B -184M -180M -7.86B | -48.77M -56.09M -44.86M -42.2M -79.07M -5.33B -79.94M -533M -207M -2.6B -211M -206M -9.01B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/06/26 | 4.310 € | -1.82% | 50 |
| 16/06/26 | 4.390 € | -0.68% | 123 |
| 15/06/26 | 4.420 € | +3.46% | 1,078 |
| 12/06/26 | 4.272 € | +5.01% | 91 |
| 11/06/26 | 4.068 € | +3.25% | 692 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADOC Stock
- 0QAI Stock
Select your edition
All financial news and data tailored to specific country editions
